The Core M2 system features an intuitive interface for optimal ease of use as well as guided workflows and uniform controls to simplify staff training.
Sterile field control
The Core M2 system features a large touch screen for sterile field control, with the ability to drive from the sterile field. Only Philips offers the plug-and-play simplicity of digital IVUS and touchscreen control from the sterile field to get to your information faster.
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also enables analysis of crucial parameters – like luminal cross-sectional measurements – and helps aid in disease diagnosis.
Grayscale enhances procedures
Grayscale enhances angiography procedures by enabling detailed views. Angiography produces a shadowgram of contrast, while IVUS visualizes extent and location of plaque, enabling precise disease assessment, vessel and optimal stent placement. IVUS guidance has been associated with a 74% change in PCI strategy and reduced MACE, MI, TLR, and death in large studies.¹, ²
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral vessels, including, superficial femoral artery and iliac artery. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque.
Core M2 is not available in all countries – please check with your local Philips representative, if you do not have it already.
1. Witzenbichler B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470
2. Ahn et al. Meta-Analysis of Outcomes After Intravascular Ultrasound Guided Versus Angiography-Guided Drug-Eluting Stent Implantation in 26,503 Patients Enrolled in Three Randomized Trials and 14 Observational Studies. Am J Cardiol 2014; 113:1338-1347
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.